NuTissu
Overview:
NuTissu Ltd is a cutting-edge biotech startup within the AINAD portfolio, specialising in the development of innovative solutions for tissue healing and regeneration.
Key Features:
- E-Plasters® Technology: NuTissu is developing E-Plasters®, miniaturized electrotherapy devices that help “re-boot” the body’s natural bioelectric current to promote tissue healing and regeneration. This technology is designed to be simple, cost-effective, and user-friendly.
- Research and Development: The company has a strong focus on research and development, collaborating with academic institutions and leveraging government funding to advance its technologies.
- Clinical Applications: NuTissu’s solutions are aimed at addressing chronic wounds and other tissue-related health issues, providing a significant improvement over current treatment options and reducing the need for frequent dressing changes.
Impact:
NuTissu’s innovative approach to tissue healing has the potential to significantly improve wound repair and recovery, especially for veterans and individuals with chronic wounds. The company’s commitment to research and collaboration ensures that its technologies are both effective and accessible, making a substantial impact in the healthcare sector.
